Overview
- 88 inspections across 76 sites are on record.
- 168 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-09-30.
At a glance
Inspections
88
Sites
76
Observations
168
Career since
Apr 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 30 Sep 2016 | Human Drugs | On file |
| Lonza Biologics, Inc. | 26 Aug 2016 | Human Drugs | On file |
| Curia Massachusetts, Inc. | 13 Jul 2016 | Human Drugs | View 483 → |
| Avista Pharma Solutions, Inc. | 15 Jun 2016 | Human Drugs | On file |
| Lantheus Medical Imaging, Inc. | 24 May 2016 | Human Drugs |
Sites inspected
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndover, United States1 insp.
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Curia Massachusetts, Inc.Burlington, United States1 insp.
Avista Pharma Solutions, Inc.Agawam, United States1 insp.
Lantheus Medical Imaging, Inc.North Billerica, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Debra M Emerson13 shared
Amy C Jordan10 shared
Mary-Jeanet Mcgarry7 shared
John P Mistler6 shared
Ramon E Martinez5 shared
Megan A Haggerty4 shared
Philip Kreiter3 shared
Leo B Zadecky3 shared
Erik W Koester2 shared
Arie Menachem2 shared
Full investigator report
Get the verbatim findings behind Stacey S Degarmo's 168 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site